The University of Helsinki's Myocopia project has developed a groundbreaking technology for cultivated meat production using stem cells, eliminating the need for expensive growth factors. By modifying cellular metabolism, the team can control the division and differentiation of muscle stem cells in bioreactors, allowing for cost-effective production of meat at scale. The technology has attracted funding from Business Finland for commercialization, with plans to license the innovation to support the growing number of cultivated meat companies looking to revolutionize food production.
Instead of becoming a cultivated meat producer, Myocopia aims to establish a spinout company to license its patented technology. The team is seeking corporate partners and investors to pilot and support the innovative growth media replacement method, with a focus on empowering companies developing cultivated meat products. This game-changing technology has the potential to transform the industry and provide accessible, sustainable meat alternatives to the market.
*This summary was generated using AI.
Read Full Article